Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Buy
70
GBDC Quote, Financials, Valuation and Earnings
Last price:
$15.21
Seasonality move
:
-1.87%
Day range:
$15.28 - $15.36
52-week range:
$14.05 - $17.72
Dividend yield:
10.75%
P/E ratio:
10.89x
P/S ratio:
11.34x
P/B ratio:
1.01x
Volume:
1.6M
Avg. volume:
1.3M
1-year change:
1.59%
Market cap:
$4.1B
Revenue:
$272.6M
EPS (TTM):
$1.41
Analysts' Opinion
-
Consensus RatingGolub Capital BDC has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Golub Capital BDC has an estimated upside of 5.86% from its current price of $15.35.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $15.35.
Fair Value
-
According to the consensus of 0 analysts, Golub Capital BDC has 5.86% upside to fair value with a price target of -- per share.
GBDC vs. S&P 500
-
Over the past 5 trading days, Golub Capital BDC has overperformed the S&P 500 by 2.65% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Golub Capital BDC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Golub Capital BDC revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Golub Capital BDC reported revenues of $94.2M.
Earnings Growth
-
Golub Capital BDC earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Golub Capital BDC reported earnings per share of $0.36.
Enterprise value:
8.5B
EV / Invested capital:
0.99x
Price / LTM sales:
11.34x
EV / EBIT:
17.85x
EV / Revenue:
31.28x
PEG ratio (5yr expected):
0.13x
EV / Free cash flow:
24.79x
Price / Operating cash flow:
8.98x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.96%
Net Income Margin (TTM):
97.49%
Return On Equity:
8.68%
Return On Invested Capital:
4.01%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $161.7M | $280.8M | $272.6M | $109.1M | $94.2M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.90 | $1.52 | $1.41 | $0.60 | $0.36 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $42.7M | $199.5M | $177.3M | $142.8M | $236.9M | |
| Total Assets | $4.4B | $5.2B | $5.7B | $5.7B | $8.7B | |
| Current Liabilities | $29.2M | $30.8M | $60.1M | $67.5M | $89.6M | |
| Total Liabilities | $2B | $2.6B | $3.1B | $3.2B | $4.7B | |
| Total Equity | $2.4B | $2.6B | $2.5B | $2.5B | $4B | |
| Total Debt | $2B | $2.6B | $3.1B | $3.1B | $4.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$416.5M | $195.4M | $343.9M | $64.1M | -$200M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | $353.1M | -$235.5M | -$124.2M | -$94.7M | $93.7M | |
| Free Cash Flow | -$416.5M | $195.4M | $343.9M | $64.1M | -$200M | |
GBDC
Sector
Market Cap
$4.1B
$698.9M
Price % of 52-Week High
86.63%
88.68%
Dividend Yield
10.75%
2.18%
Shareholder Yield
5.38%
3.87%
1-Year Price Total Return
1.59%
7.42%
Beta (5-Year)
0.631
0.734
Dividend yield:
10.75%
Annualized payout:
$1.89
Payout ratio:
123.53%
Growth streak:
3 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$15.05
200-day SMA
Sell
Level
$15.62
Bollinger Bands (100)
Buy
Level
14.77 - 15.39
Chaikin Money Flow
Sell
Level
-39.6M
20-day SMA
Buy
Level
$15.24
Relative Strength Index (RSI14)
Buy
Level
55.36
ADX Line
Buy
Level
25.65
Williams %R
Neutral
Level
-31.25
50-day SMA
Buy
Level
$15.30
MACD (12, 26)
Sell
Level
-0.05
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
19.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7187)
Sell
CA Score
(Annual)
Level (-0.3619)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.202)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.
Stock Forecast FAQ
In the current month, GBDC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GBDC average analyst price target in the past 3 months is --.
-
Where Will Golub Capital BDC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Golub Capital BDC share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Golub Capital BDC?
Analysts are divided on their view about Golub Capital BDC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Golub Capital BDC is a Sell and believe this share price will drop from its current level to --.
-
What Is Golub Capital BDC's Price Target?
The price target for Golub Capital BDC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GBDC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Golub Capital BDC is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GBDC?
You can purchase shares of Golub Capital BDC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Golub Capital BDC shares.
-
What Is The Golub Capital BDC Share Price Today?
Golub Capital BDC was last trading at $15.21 per share. This represents the most recent stock quote for Golub Capital BDC. Yesterday, Golub Capital BDC closed at $15.35 per share.
-
How To Buy Golub Capital BDC Stock Online?
In order to purchase Golub Capital BDC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 9.7% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 2.48% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.45% over the past day.
